Action-at-a-Distance Mutations Induced by the True Abasic Site, Uracil, and Nicks: Unexpectedly Lower Mutagenicity of the True Abasic Site.

IF 1.7 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Tetsuya Suzuki, Kiyoharu Yasui, Hiroki Takata, Yasuo Komatsu, Hiroyuki Kamiya
{"title":"Action-at-a-Distance Mutations Induced by the True Abasic Site, Uracil, and Nicks: Unexpectedly Lower Mutagenicity of the True Abasic Site.","authors":"Tetsuya Suzuki, Kiyoharu Yasui, Hiroki Takata, Yasuo Komatsu, Hiroyuki Kamiya","doi":"10.1248/bpb.b25-00366","DOIUrl":null,"url":null,"abstract":"<p><p>A major oxidized base, 8-oxo-7,8-dihydroguanine (G<sup>O</sup>, 8-hydroxyguanine), is involved in cancer initiation. G<sup>O</sup> induces untargeted base substitution (action-at-a-distance) mutations as well as targeted G→T transversions in human cells. Uracil also induces similar untargeted mutations. An abasic site is the common product of their specific DNA glycosylases (OGG1 and UNG2, respectively) and is an expected intermediate of the untargeted mutation pathway. Subsequently, the DNA strand is nicked by AP endonuclease. In this study, a shuttle plasmid containing a true (natural) abasic site was introduced into human U2OS cells. The frequency of action-at-a-distance mutations was much lower for the abasic site than that for uracil, although the abasic site is considered the mutational intermediate of the latter. Moreover, nicked DNA containing a 5'-phosphate induced untargeted mutations less frequently than that without a 5'-phosphate, and their mutation frequencies were much higher than that of the abasic site. The unexpectedly low mutagenic potential of the true abasic site suggests that the mechanism of action-at-a-distance mutations is complex.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 7","pages":"1111-1117"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b25-00366","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

A major oxidized base, 8-oxo-7,8-dihydroguanine (GO, 8-hydroxyguanine), is involved in cancer initiation. GO induces untargeted base substitution (action-at-a-distance) mutations as well as targeted G→T transversions in human cells. Uracil also induces similar untargeted mutations. An abasic site is the common product of their specific DNA glycosylases (OGG1 and UNG2, respectively) and is an expected intermediate of the untargeted mutation pathway. Subsequently, the DNA strand is nicked by AP endonuclease. In this study, a shuttle plasmid containing a true (natural) abasic site was introduced into human U2OS cells. The frequency of action-at-a-distance mutations was much lower for the abasic site than that for uracil, although the abasic site is considered the mutational intermediate of the latter. Moreover, nicked DNA containing a 5'-phosphate induced untargeted mutations less frequently than that without a 5'-phosphate, and their mutation frequencies were much higher than that of the abasic site. The unexpectedly low mutagenic potential of the true abasic site suggests that the mechanism of action-at-a-distance mutations is complex.

真基位点、尿嘧啶和尼克斯诱导的远距离作用突变:真基位点的致突变性出乎意料地低。
一个主要的氧化碱,8-氧-7,8-二氢鸟嘌呤(GO, 8-羟基鸟嘌呤),参与了癌症的发生。氧化石墨烯在人类细胞中诱导非靶向碱基置换(远距离作用)突变以及靶向G→T转化。尿嘧啶也能诱导类似的非靶向突变。一个基本位点是它们特定DNA糖基酶(分别为OGG1和UNG2)的共同产物,是非靶向突变途径的预期中间产物。随后,DNA链被AP内切酶切割。在本研究中,将一个含有真(天然)碱基位点的穿梭质粒引入人U2OS细胞。尽管基础位点被认为是后者的突变中间体,但与尿嘧啶相比,其近距离作用突变的频率要低得多。此外,含有5'-磷酸的缺口DNA诱导非靶向突变的频率低于不含5'-磷酸的缺口DNA,其突变频率远高于基础位点的突变频率。真正的基本位点出乎意料的低致突变潜能表明,远距离作用突变的机制是复杂的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
247
审稿时长
2 months
期刊介绍: Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012. The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信